Literature DB >> 26214139

Autologous reconstitution leading to sustained JAK2-V617F negativity post allogeneic hematopoietic stem cell transplant in JAK2-V617F positive myelofibrosis.

P Torka1, T Hahn1, J Bertolo1, H Liu1, M Ross1, P Paplham1, A Jankowski2, G Deeb3, G Chen1, P McCarthy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26214139     DOI： 10.1038/bmt.2015.169

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

1.  Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population.

Authors:  S Maury; K Belhadj; I Chami; M Kuentz; C Cordonnier; D Bories
Journal:  Bone Marrow Transplant       Date:  2001-10       Impact factor: 5.483

Review 2.  Management of essential thrombocythemia.

Authors:  Francisco Cervantes
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

3.  Durable molecular remission in a patient with chronic myelogenous leukemia and host-derived hematopoiesis after allogeneic bone marrow transplantation.

Authors:  M Wakui; S Okamoto; A Ishida; R Tanosaki; T Mori; Y Kawai; S Ohshima; Y Ikeda
Journal:  Bone Marrow Transplant       Date:  1996-10       Impact factor: 5.483

4.  Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation.

Authors:  Bimalangshu R Dey; Steven McAfee; Christine Colby; Kathy Cieply; Martin Caron; Susan Saidman; Frederic Preffer; Juanita Shaffer; Nancy Tarbell; Robert Sackstein; David Sachs; Megan Sykes; Thomas R Spitzer
Journal:  Br J Haematol       Date:  2005-02       Impact factor: 6.998

5.  Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse.

Authors:  C G Brunstein; B A Hirsch; J S Miller; R C McGlennen; C M Verfaillie; P B McGlave; D J Weisdorf
Journal:  Bone Marrow Transplant       Date:  2000-12       Impact factor: 5.483

6.  Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Nicolaus Kröger; Ernst Holler; Guido Kobbe; Martin Bornhäuser; Rainer Schwerdtfeger; Herrad Baurmann; Arnon Nagler; Wolfgang Bethge; Matthias Stelljes; Lutz Uharek; Hannes Wandt; Andreas Burchert; Paolo Corradini; Jörg Schubert; Martin Kaufmann; Peter Dreger; Gerald G Wulf; Hermann Einsele; Tatjana Zabelina; Hans Michael Kvasnicka; Jürgen Thiele; Ronald Brand; Axel R Zander; Dietger Niederwieser; Theo M de Witte
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

7.  Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment.

Authors:  E Daguindau; B Lioure; A Buzyn; M Robin; C Faucher; M Kuentz; P Tiberghien; E Deconinck
Journal:  Bone Marrow Transplant       Date:  2009-05-11       Impact factor: 5.483

8.  Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning.

Authors:  G L Chen; Y Zhang; T Hahn; S Abrams; M Ross; H Liu; P L McCarthy
Journal:  Bone Marrow Transplant       Date:  2013-10-28       Impact factor: 5.483

9.  Autologous reconstitution with BCR-ABL-negative haematopoiesis after T cell-depleted allogeneic BMT for CML.

Authors:  J Serrano; J Román; J A Castillejo; J Sánchez; J A Navarro; C Martín; C Herrera; A Torres
Journal:  Bone Marrow Transplant       Date:  1998-09       Impact factor: 5.483

10.  Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma.

Authors:  Marie-Therese Rubio; Yong-Mi Kim; Teviah Sachs; Markus Mapara; Guiling Zhao; Megan Sykes
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113
View more
  1 in total

1.  Systems-Based Interactome Analysis for Hematopoiesis Effect of Angelicae sinensis Radix: Regulated Network of Cell Proliferation towards Hemopoiesis.

Authors:  Guang Zheng; He Zhang; Yun Yang; Ying-Li Sun; Yan-Jing Zhang; Ju-Ping Chen; Ting Hao; Cheng Lu; Hong-Tao Guo; Ge Zhang; Dan-Ping Fan; Xiao-Juan He; Ai-Ping Lu
Journal:  Chin J Integr Med       Date:  2018-06-25       Impact factor: 1.978
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.